ロード中...
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy
OBJECTIVES: We assessed the impact of tocilizumab (TCZ), a humanised monoclonal anti-interleukin-6 receptor antibody, on antibody response following administration of the 23-valent pneumococcal polysaccharide vaccine (PPV23). METHODS: A total of 190 patients with rheumatoid arthritis (RA) received P...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3711492/ https://ncbi.nlm.nih.gov/pubmed/23345600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2012-202658 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|